trending Market Intelligence /marketintelligence/en/news-insights/trending/038o7vlllhii23egk9gdjq2 content esgSubNav
In This List

Cytori Therapeutics falls out of compliance with Nasdaq listing requirements

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Cytori Therapeutics falls out of compliance with Nasdaq listing requirements

Cytori Therapeutics Inc. said it fell out of compliance with the Nasdaq Stock Market LLC's listing requirements.

The Nasdaq said in a notice that the San Diego-based company failed to maintain a minimum bid price of $1 per share for the last 30 consecutive business days.

Cytori Therapeutics has until Feb. 25, 2019, to regain compliance with the listing requirement, the company said in an SEC filing.

The company had recently regained compliance with Nasdaq's minimum bid price rule after implementing a 1-for-10 reverse stock split.